8% Off
Tamona20 mg
Beximco Pharmaceuticals Ltd.
৳147.84
Add to cart
Generic medicine
Tamoxifen Citrate: Brands, Price & Uses in Bangladesh
Tamoxifen Citrate is a nonsteroidal selective estrogen receptor modulator (SERM) indicated in the following settings: Established / FDA-approved uses Adjuvant treatment of breast cancer : Tamoxifen…
About Tamoxifen Citrate
Indications of Tamoxifen Citrate
Tamoxifen Citrate is a nonsteroidal selective estrogen receptor modulator (SERM) indicated in the following settings:
Established / FDA-approved uses
- Adjuvant treatment of breast cancer: Tamoxifen Citrate is indicated for adjuvant treatment of hormone receptor-positive breast cancer in women, including in node-positive disease following surgery/radiation, to reduce the risk of recurrence.
- Metastatic breast cancer: Tamoxifen Citrate is indicated for the treatment of hormone receptor-positive metastatic breast cancer in women and in men.
- Reduction of contralateral breast cancer: Tamoxifen Citrate is indicated to reduce the incidence of a new cancer in the opposite breast in women receiving treatment for breast cancer.
- Reduction of breast cancer risk in high-risk women (chemoprevention): Tamoxifen Citrate is indicated to reduce the incidence of invasive breast cancer in women at high risk, based on age, family history, prior biopsy findings, and other validated risk-assessment tools.
- Ductal carcinoma in situ (DCIS): Tamoxifen Citrate is indicated to reduce the risk of invasive breast cancer in women with DCIS, following surgery and radiation, to reduce the risk of a subsequent breast cancer.
Off-label use (not FDA-approved)
- Ovulation induction: Tamoxifen Citrate is used off-label in some fertility settings, generally when standard agents are unsuitable or unavailable; this use requires specialist supervision and is not an approved indication.
- Gynecomastia and mastalgia: Tamoxifen Citrate is sometimes used off-label for painful gynecomastia or mastalgia under specialist care.
The balance of benefit and serious risk (see Precautions and Warnings) differs substantially between treatment of existing cancer and use for risk reduction in otherwise healthy women, and this should be discussed individually with a physician.
Dosage & Administration of Tamoxifen Citrate
Tamoxifen Citrate is taken orally, with or without food, generally once or twice daily depending on total dose. Tablets should be swallowed whole and taken at approximately the same time(s) each day. Treatment duration and total dose depend on the specific indication (see table below) and should be individualized by the prescribing physician.
| Indication | Typical adult dose | Typical duration |
|---|---|---|
| Adjuvant treatment, breast cancer (women and men) | 20 mg once daily (doses above 20 mg/day are usually given in divided doses, morning and evening) | Commonly 5 years; extended therapy up to 10 years may be considered in selected patients based on specialist assessment |
| Metastatic breast cancer | 20 mg once daily, up to 40 mg/day in divided doses in some regimens | Until disease progression or unacceptable toxicity, per oncologist |
| Reduction of contralateral breast cancer risk / DCIS | 20 mg once daily | Typically 5 years |
| Breast cancer risk reduction in high-risk women | 20 mg once daily | Typically 5 years |
Missed dose: if a dose of Tamoxifen Citrate is missed, it should be taken as soon as remembered unless it is nearly time for the next dose, in which case the missed dose should be skipped; doses should not be doubled. Patients should not stop Tamoxifen Citrate without discussing with their physician, as premature discontinuation can affect cancer treatment outcomes.
Side Effects of Tamoxifen Citrate
Serious risks (boxed-warning level) associated with Tamoxifen Citrate include:
- Uterine malignancies: increased risk of endometrial cancer and uterine sarcoma, particularly with long-term use; patients should promptly report any abnormal vaginal bleeding, spotting, or discharge.
- Stroke: increased risk, particularly in postmenopausal women, especially those using Tamoxifen Citrate for risk reduction.
- Pulmonary embolism and deep vein thrombosis: increased risk of blood clots, which can be serious or life-threatening.
These serious risks must be weighed individually against the benefit of Tamoxifen Citrate, which differs between women being treated for existing breast cancer and healthy high-risk women taking it for prevention.
Common side effects
- Hot flashes and flushing
- Night sweats
- Vaginal discharge, dryness, or itching
- Menstrual irregularities or amenorrhea
- Nausea
- Fluid retention/mild swelling
- Mood changes, irritability, or depressed mood
- Fatigue and headache
- Weight change and mild hair thinning
Less common but important side effects
- Ocular changes with long-term use, including cataracts and, rarely, retinopathy or corneal changes
- Hepatic effects, including rare fatty liver changes or abnormal liver enzymes
- Hypercalcemia and tumor flare (transient increase in bone pain or tumor-site symptoms) shortly after starting treatment in patients with bone metastases
- Rare severe skin reactions
Patients should seek urgent medical attention for leg swelling/pain, sudden breathlessness, chest pain, sudden vision changes, one-sided weakness, or abnormal vaginal bleeding while on Tamoxifen Citrate.
Contraindications of Tamoxifen Citrate
Tamoxifen Citrate is contraindicated in:
- Patients with known hypersensitivity to tamoxifen or any component of the formulation.
- Concurrent use with warfarin or other coumarin-type anticoagulants, specifically in women receiving Tamoxifen Citrate for reduction of breast cancer risk or for treatment of ductal carcinoma in situ (DCIS), because of increased bleeding risk in this lower-risk population.
- Women with a history of deep vein thrombosis (DVT) or pulmonary embolism (PE) who are being considered for Tamoxifen Citrate for reduction of breast cancer risk or DCIS, given the drug's own thromboembolic risk in this preventive setting.
- Pregnancy, because of the potential for fetal harm (see Pregnancy and Lactation).
Tamoxifen Citrate should be used with caution and only after careful individual risk-benefit assessment in women being treated for active breast cancer who have other risk factors for the above conditions; this differs from the absolute contraindications applicable to the risk-reduction/DCIS indications above.
Frequently Asked Questions about Tamoxifen Citrate
What is Tamoxifen Citrate used for?
Tamoxifen Citrate is a selective estrogen receptor modulator (SERM) used to treat hormone receptor-positive breast cancer (in both women and men), to reduce the risk of a new cancer in the opposite breast, to reduce the risk of invasive breast cancer in women with ductal carcinoma in situ (DCIS), and to reduce breast cancer risk in women who are at high risk based on family history and other factors. It is sometimes used off-label for ovulation induction under specialist supervision.
What are the most serious risks of Tamoxifen Citrate?
Tamoxifen Citrate carries well-established, serious risks that must be discussed with a physician before starting treatment: an increased risk of uterine cancer (endometrial cancer and uterine sarcoma), an increased risk of stroke, and an increased risk of blood clots such as pulmonary embolism and deep vein thrombosis. Patients should promptly report abnormal vaginal bleeding, leg swelling or pain, sudden breathlessness, chest pain, or sudden weakness/vision changes while taking Tamoxifen Citrate.
Can I take Tamoxifen Citrate during pregnancy or while breastfeeding?
No. Tamoxifen Citrate is contraindicated during pregnancy because it can cause fetal harm, and effective non-hormonal contraception is required during treatment and for a period afterward, as advised by your physician. Tamoxifen Citrate should generally be avoided while breastfeeding; discuss feeding options with your doctor before starting or continuing treatment.
Can Tamoxifen Citrate be taken together with warfarin or antidepressants?
Tamoxifen Citrate can interact significantly with warfarin (and similar anticoagulants), increasing bleeding risk; this combination is contraindicated in women taking Tamoxifen Citrate for breast cancer risk reduction or DCIS, and requires close monitoring in women being treated for active breast cancer. Certain antidepressants (such as paroxetine and fluoxetine) can reduce the conversion of Tamoxifen Citrate to its active form and potentially reduce its effectiveness, so your doctor may recommend an alternative antidepressant if one is needed alongside Tamoxifen Citrate.
How long is Tamoxifen Citrate usually taken for?
Duration depends on the reason for treatment. For adjuvant treatment of breast cancer, Tamoxifen Citrate is commonly taken for 5 years, and sometimes extended up to 10 years in selected patients based on specialist assessment. For breast cancer risk reduction or DCIS, a 5-year course is typical. For metastatic breast cancer, Tamoxifen Citrate is usually continued until the disease progresses or side effects become unacceptable. Always follow your physician's specific instructions and do not stop early without medical advice.
What should I do if I miss a dose or suspect an overdose of Tamoxifen Citrate?
If you miss a dose of Tamoxifen Citrate, take it as soon as you remember unless it is almost time for your next dose, in which case skip the missed dose — do not double up. If you suspect an overdose of Tamoxifen Citrate, treat it as a medical emergency: seek immediate medical attention or contact a poison control center right away rather than trying to manage it at home.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.